Keywords
Last Name
Institution

BAMBI JO GRILLEY

TitleAssistant Professor
InstitutionBaylor College of Medicine
DepartmentDepartment of Pediatrics
AddressDepartment of Pediatrics - Hem/Onc Clinical Research
1102 Bates St., C1770
Houston TX 77030
vCardDownload vCard
    Other Positions
    TitleAssistant Professor
    InstitutionBaylor College of Medicine
    DepartmentCenter for Cell & Gene Therapy
    DivisionCenter for Cell & Gene Therapy


    Collapse Additional Tools and Researcher Information 
    Collapse Featured Presentations
    Collapse Faculty Mentor
    Collapse Publication Export
    Collapse Aliases
    Collapse Verify Publications

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Ramos CA, Savoldo B, Torrano V, Ballard B, Zhang H, Dakhova O, Liu E, Carrum G, Kamble RT, Gee AP, Mei Z, Wu MF, Liu H, Grilley B, Rooney CM, Brenner MK, Heslop HE, Dotti G; . Clinical responses with T lymphocytes targeting malignancy-associated ? light chains. JCI. 2016; 7(126):2588-96.
    2. Ramos CA, Savoldo B, Torrano V, Ballard B, Zhang H, Dakhova O, Liu E, Carrum G, Kamble RT, Gee AP, Mei Z, Wu MF, Liu H, Grilley B, Rooney CM, Brenner MK, Heslop HE, Dotti G. Clinical responses with T lymphocytes targeting malignancy-associated ? light chains. J Clin Invest. 2016 Jun 6. PMID: 27270177.
      View in: PubMed
    3. Grilley BJ. Ethical Considerations in Pediatric Stem Cell Donation. BBMT. 2016; 1(22):3.
    4. Grilley BJ. Ethical Considerations in Pediatric Stem Cell Donation. Biol Blood Marrow Transplant. 2016 Jan; 22(1):3. PMID: 26585503.
      View in: PubMed
    5. Zhou X, Dotti G, Krance RA, Martinez CA, Naik S, Kamble RT, Durett AG, Dakhova O, Savoldo B, Di Stasi A, Spencer DM, Lin YF, Liu H, Grilley BJ, Gee AP, Rooney CM, Heslop HE, Brenner MK. Inducible caspase-9 suicide gene controls adverse effects from alloreplete T cells after haploidentical stem cell transplantation. Blood. 2015 Jun 25; 125(26):4103-13. PMID: 25977584.
      View in: PubMed
    6. Ahmed N, Brawley VS, Hegde M, Robertson C, Ghazi A, Gerken C, Liu E, Dakhova O, Ashoori A, Corder A, Gray T, Wu MF, Liu H, Hicks J, Rainusso N, Dotti G, Mei Z, Grilley B, Gee A, Rooney CM, Brenner MK, Heslop HE, Wels WS, Wang LL, Anderson P, Gottschalk S. Human Epidermal Growth Factor Receptor 2 (HER2) -Specific Chimeric Antigen Receptor-Modified T Cells for the Immunotherapy of HER2-Positive Sarcoma. J Clin Oncol. 2015 May 20; 33(15):1688-96. PMID: 25800760; PMCID: PMC4429176.
    7. Zhou X, Di Stasi A, Tey SK, Krance RA, Martinez C, Leung KS, Durett AG, Wu MF, Liu H, Leen AM, Savoldo B, Lin YF, Grilley BJ, Gee AP, Spencer DM, Rooney CM, Heslop HE, Brenner MK, Dotti G. Long-term outcome after haploidentical stem cell transplant and infusion of T cells expressing the inducible caspase 9 safety transgene. Blood. 2014 Jun 19; 123(25):3895-905. PMID: 24753538; PMCID: PMC4064331.
    8. Grilley BJ. Drug Information: A Guide for Pharmacists. Investigational Drugs in the Principles and Practice of Drug Information. 2014.
    9. Grilley BJ. Cancer Gene Therapy by Viral and Non-viral Vectors. Regulations Governing Clinical Trials in Gene Therapy. 2014.
    10. Cruz CR, Micklethwaite KP, Savoldo B, Ramos CA, Lam S, Ku S, Diouf O, Liu E, Barrett AJ, Ito S, Shpall EJ, Krance RA, Kamble RT, Carrum G, Hosing CM, Gee AP, Mei Z, Grilley BJ, Heslop HE, Rooney CM, Brenner MK, Bollard CM, Dotti G. Infusion of donor-derived CD19-redirected virus-specific T cells for B-cell malignancies relapsed after allogeneic stem cell transplant: a phase 1 study. Blood. 2013 Oct 24; 122(17):2965-73. PMID: 24030379; PMCID: PMC3811171.
    11. Leen AM, Bollard CM, Mendizabal AM, Shpall EJ, Szabolcs P, Antin JH, Kapoor N, Pai SY, Rowley SD, Kebriaei P, Dey BR, Grilley BJ, Gee AP, Brenner MK, Rooney CM, Heslop HE. Multicenter study of banked third-party virus-specific T cells to treat severe viral infections after hematopoietic stem cell transplantation. Blood. 2013 Jun 27; 121(26):5113-23. PMID: 23610374; PMCID: PMC3695359.
    12. Grilley BJ. Submitting and Conducting a Sponsor-Investigator IND: Lessons Learned...The Hard Way. SoCRA Source. 2012; (72):26-32.
    13. Grilley, BJ . Drug Information: A Guide for Pharmacists. Investigational Drugs in the Principles and Practice of Drug Information. 2012.
    14. Di Stasi A, Tey SK, Dotti G, Fujita Y, Kennedy-Nasser A, Martinez C, Straathof K, Liu E, Durett AG, Grilley B, Liu H, Cruz CR, Savoldo B, Gee AP, Schindler J, Krance RA, Heslop HE, Spencer DM, Rooney CM, Brenner MK. Inducible apoptosis as a safety switch for adoptive cell therapy. N Engl J Med. 2011 Nov 3; 365(18):1673-83. PMID: 22047558; PMCID: PMC3236370.
    15. Savoldo B, Ramos CA, Liu E, Mims MP, Keating MJ, Carrum G, Kamble RT, Bollard CM, Gee AP, Mei Z, Liu H, Grilley B, Rooney CM, Heslop HE, Brenner MK, Dotti G. CD28 costimulation improves expansion and persistence of chimeric antigen receptor-modified T cells in lymphoma patients. J Clin Invest. 2011 May; 121(5):1822-6. PMID: 21540550; PMCID: PMC3083795.
    16. Grilley, BJ; Berg, S; Boudreaux, C. . Regulatory and Ethical Issues in the Treatment of Children. 2007.
    17. Noel, F; Grilley, BJ. A Peer Reviewed Quality Assurance Program at a Clinical Research Site. ACRP Monitor. 2006; 1-5.
    18. Grilley BJ. Data Safety Monitoring: A Practical Guide for Clinical Researchers. NCURA Newsletter. 2006; XXXVIII:6-7.
    19. Grilley BJ. Drug Information: A Guide for Pharmacists. Investigational Drugs in the Principles and Practice of Drug Information. 2006.
    20. Grilley, BJ . Institutional Review Board: Management and Function. Gene Therapy Oversight. 2006.
    21. Grilley BJ. Improve Quality with a Trial Monitoring Program. Clinical Trials Administrator. 2005; 3:127-130.
    22. Rousseau RF, Biagi E, Dutour A, Yvon ES, Brown MP, Lin T, Mei Z, Grilley B, Popek E, Heslop HE, Gee AP, Krance RA, Popat U, Carrum G, Margolin JF, Brenner MK. Immunotherapy of high-risk acute leukemia with a recipient (autologous) vaccine expressing transgenic human CD40L and IL-2 after chemotherapy and allogeneic stem cell transplantation. Blood. 2006 Feb 15; 107(4):1332-41. PMID: 16249392; PMCID: PMC1895421.
    23. Biagi E, Rousseau R, Yvon E, Schwartz M, Dotti G, Foster A, Havlik-Cooper D, Grilley B, Gee A, Baker K, Carrum G, Rice L, Andreeff M, Popat U, Brenner M. Responses to human CD40 ligand/human interleukin-2 autologous cell vaccine in patients with B-cell chronic lymphocytic leukemia. Clin Cancer Res. 2005 Oct 1; 11(19 Pt 1):6916-23. PMID: 16203783.
      View in: PubMed
    24. Grilley BJ. Data Review Committees Offer Additional Protection. Clinical Trials Administrator. 2005; 3:101-102.
    25. Grilley, BJ. Study Guide for Institutional Review Board Management and Function. Gene Therapy Oversight. 2005.
    26. Grilley BJ, Gee AP. Gene transfer: regulatory issues and their impact on the clinical investigator and the good manufacturing production facility. Cytotherapy. 2003; 5(3):197-207. PMID: 12850787.
      View in: PubMed
    27. Rousseau RF, Haight AE, Hirschmann-Jax C, Yvon ES, Rill DR, Mei Z, Smith SC, Inman S, Cooper K, Alcoser P, Grilley B, Gee A, Popek E, Davidoff A, Bowman LC, Brenner MK, Strother D. Local and systemic effects of an allogeneic tumor cell vaccine combining transgenic human lymphotactin with interleukin-2 in patients with advanced or refractory neuroblastoma. Blood. 2003 Mar 1; 101(5):1718-26. PMID: 12406881.
      View in: PubMed
    28. Kramer M, Grilley BJ. Gaining Access to Investigational Drugs for Treatment: An Investigational New Drug Application Primer. International Journal of Pharmaceutical Compounding. 2002; 6:271-273.
    29. Kramer MA, Grilley BJ. Gaining access to investigational drugs for treatment: an investigational new drug application primer. Int J Pharm Compd. 2002 Jul-Aug; 6(4):271-3. PMID: 23979304.
      View in: PubMed
    30. Grilley, BJ. Study Guide for Institutional Review Board: Management and Function. Gene Therapy Oversight. 2002.
    31. Grilley, BJ. Institutional Review Board: Management and Function. Gene Therapy Oversight. 2002.
    32. Grilley, BJ. Drug Information: A Guide for Pharmacists. Investigational Drugs in the Principles and Practice of Drug Information. 2001.
    33. Grilley BJ, Aguilar LK, Aguilar-Cordova E. Reporting adverse events in gene therapy studies. BioDrugs. 2000 Sep; 14(3):141-5. PMID: 18034566.
      View in: PubMed
    34. Brenner MK, Heslop H, Krance R, Horowitz M, Strother D, Nuchtern J, Grilley B, Martingano E, Cooper K. Phase I study of chemokine and cytokine gene-modified autologous neuroblastoma cells for treatment of relapsed/refractory neuroblastoma using an adenoviral vector. Hum Gene Ther. 2000 Jul 1; 11(10):1477-88. PMID: 10910144.
      View in: PubMed
    35. Heslop H, Rooney C, Brenner M, Krance R, Carrum G, Gahn B, Bollard C, Khan S, Gee A, Popat U, Gresik M, Przepiorka D, Kuehnle I, Grilley B. Administration of neomycin resistance gene-marked EBV-specific cytotoxic T-lymphocytes as therapy for patients receiving a bone marrow transplant for relapsed EBV-positive Hodgkin disease. Hum Gene Ther. 2000 Jul 1; 11(10):1465-75. PMID: 10910143.
      View in: PubMed
    36. Roskrow MA, Rooney CM, Heslop HE, Brenner MK, Krance RA, Gresik MV, McClain K, Aguilar LK, Grilley B, Rob E, Carrum G. Administration of neomycin resistance gene marked EBV specific cytotoxic T-lymphocytes to patients with relapsed EBV-positive Hodgkin disease. Hum Gene Ther. 1998 May 20; 9(8):1237-50. PMID: 9625264.
      View in: PubMed
    37. Grilley, BJ. Drug Information: A Guide for Pharmacists. Investigational Drugs in the Principles and Practice of Drug Information. 1996.
    38. Grilley BJ, Trissel LA, Bluml BM. Design and implementation of an electronic investigational drug accountability system. Am J Hosp Pharm. 1991 Dec; 48(12):2616-8. PMID: 1814202.
      View in: PubMed
    39. Trissel LA, Tramonte SM, Grilley BJ. Visual compatibility of ondansetron hydrochloride with selected drugs during simulated Y-site injection. Am J Hosp Pharm. 1991 May; 48(5):988-92. PMID: 1830190.
      View in: PubMed
    40. Grilley, BJ. Fludarabine phosphate: a new agent for lymphoproliferative malignancies. The Cancer Bulletin. 1991; 43:583-584.
    GRILLEY's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _